Rare Case Presentation of Bilateral Triple-Negative Breast Cancer in a Premenopausal Woman: A Case Report
DOI:
https://doi.org/10.55320/mjz.53.3.1151Keywords:
Bilateral breast cancer, Triple-negative breast cancer, Synchronous, Neoadjuvant chemotherapy, Modified radical mastectomy, radiotherapy access, Case reportAbstract
A 39-year-old premenopausal woman presented after approximately one year of bilateral breast lumps and was diagnosed with synchronous bilateral invasive carcinoma of no special type with a triple-negative phenotype (ER-negative, PR-negative and HER2-negative) and Ki-67 indices of 45-50%. Clinical/radiological staging was cT4a cN1 M0 (stage IIIB) on the right and cT2 cN1 M0 (stage IIB) on the left. She completed six cycles of neoadjuvant carboplatin plus paclitaxel, with an estimated partial response of approximately 60%, followed by bilateral modified radical mastectomy and level II axillary lymph-node dissection. Postmastectomy histology confirmed residual invasive carcinoma; margins were negative on the left but positive at the superior and posterior margins on the right. A pathological complete response was therefore not achieved. Postmastectomy radiotherapy was recommended but could not be delivered because it was unavailable at the treating facility and access elsewhere was financially constrained. At one month she was clinically well; at six months the available record documented good recovery without new adverse events, although no interval imaging or laboratory surveillance was recorded. This case highlights the clinical complexity of synchronous bilateral triple-negative breast cancer and the consequences of gaps in genetic testing, systemic treatment options and radiotherapy access in resource-limited settings.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Medical Journal of Zambia

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.






